Supplemental material
Leukemia & Lymphoma
Volume 57, 2016 - Issue 12
Open access
5,856
Views
9
CrossRef citations to date
0
Altmetric
Original Article: Clinical
Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS)
Philippe MoreauHematology Department, University Hospital Hôtel-Dieu, Nantes, France; Correspondence[email protected]
, Katja C. WeiselUniversity of Tübingen, Tübingen, Germany;
, Kevin W. SongVancouver General Hospital, Vancouver, BC, Canada;
, Craig J. GibsonCelgene Corporation, Summit, NJ, USA;
, Owain SaundersBresMed Health Solutions, Sheffield, UK;
, Lars Axel SternasCelgene Corporation, Summit, NJ, USA;
, Kevin HongCelgene Corporation, Summit, NJ, USA;
, Mohamed H. ZakiCelgene Corporation, Summit, NJ, USA;
& Meletios A. DimopoulosAlexandra Hospital, Athens, Greece
show all
Pages 2839-2847
|
Received 15 Jan 2016, Accepted 13 Apr 2016, Published online: 13 May 2016
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.